- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Blau Farmaceutica SA (BLAU3)
Blau Farmaceutica SA stock price live, this page displays BVMF BLAU3 stock exchange data. View the BLAU3 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Blau Farmaceutica SA real time stock price chart below.
What Is the Blau Farmaceutica SA Stock Price Today?
The Blau Farmaceutica SA stock price today is 11.52.
What Is the Stock Symbol for Blau Farmaceutica SA?
The stock ticker symbol for Blau Farmaceutica SA is BLAU3.
Is BLAU3 the Same as $BLAU3?
$BLAU3 is a common way to refer to the Blau Farmaceutica SA ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Blau Farmaceutica SA Trade On?
Blau Farmaceutica SA is listed and trades on the B3 stock exchange.
Is Blau Farmaceutica SA a Good Stock to Buy?
Determining whether Blau Farmaceutica SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Blau Farmaceutica SA share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLAU3 quote. (ISIN: BRBLAUACNOR8)
What Is the Blau Farmaceutica SA Stock Price Today?
The Blau Farmaceutica SA stock price today is 11.52.
What Is the Stock Symbol for Blau Farmaceutica SA?
The stock ticker symbol for Blau Farmaceutica SA is BLAU3.
Is BLAU3 the Same as $BLAU3?
$BLAU3 is a common way to refer to the Blau Farmaceutica SA ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Blau Farmaceutica SA Trade On?
Blau Farmaceutica SA is listed and trades on the B3 stock exchange.
Is Blau Farmaceutica SA a Good Stock to Buy?
Determining whether Blau Farmaceutica SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Blau Farmaceutica SA share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLAU3 quote. (ISIN: BRBLAUACNOR8)
11.52
+0.35(+3.13%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.16
11.52
52 wk Range
8.57
11.58
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
11.1611.52
52 wk Range
8.5711.58
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.99%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BLAU3 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
12.85
Upside
+11.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Blau Farmacêutica S.A., a pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its products cover various areas, such as immunology, hematology, oncology, nephrology, infectology, and anesthesiology. The company offers uterine stimulator, antirheumatic, anaesthetics, antibiotics, feminine health care, biopharmaceuticals, oncologicals, hospital products, antivirals and antiretrovirals, biológicos, acid pump inhibitor, hemoderivatives, antithrombotic, and thrombolytics products. Blau Farmacêutica S.A. was incorporated in 1987 and is headquartered in Cotia, Brazil.
Blau Farmaceutica SA Earnings Call Summary for Q4/2025
- Blau Farmacêutica missed Q4 2025 forecasts with EPS of $0.23 vs. $0.27 expected and revenue of $389M vs. $484M, stock fell 5.09%.
- Annual revenue declined 3% to BRL 1.7B due to public sector bidding delays and production constraints, though net income rose 39% to BRL 297M.
- Company achieved record BRL 582M shareholder distribution and improved gross margin by 260 basis points despite operational headwinds.
- Obtained Anvisa certificate for pembrolizumab, Brazil's first biosimilar monoclonal antibody, marking strategic pivot to higher-value biologics.
- Management expects accelerated product launches in 2026 as regulatory reviews improve; capacity expansions on track to support anticipated growth.
Last Updated: 03/18/2026, 11:19 AM
Read Full TranscriptBlau Farmaceutica investor slides for Q4/2025
Last Update: Mar 18, 2026
See full investor slides
Compare BLAU3 to Peers and Sector
Metrics to compare | BLAU3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLAU3PeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.7x | −4.3x | −0.5x | |
PEG Ratio | 0.24 | −0.67 | 0.00 | |
Price / Book | 1.1x | 3.4x | 2.6x | |
Price / LTM Sales | 1.5x | 8.4x | 3.2x | |
Upside (Analyst Target) | 9.8% | 92.5% | 47.6% | |
Fair Value Upside | Unlock | 3.3% | 6.1% | Unlock |
Analyst Ratings
3 Buy
7 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 12.85
(+11.58% Upside)
Earnings
Latest Release
Mar 17, 2026
EPS / Forecast
0.20 / 0.27
Revenue / Forecast
389.4M / 484.34M
People Also Watch
FAQ
What Is the Blau Farmaceutica (BLAU3) Stock Price Today?
The Blau Farmaceutica stock price today is 11.52 BRL.
What Stock Exchange Does Blau Farmaceutica Trade On?
Blau Farmaceutica is listed and trades on the B3 Stock Exchange.
What Is the Stock Symbol for Blau Farmaceutica?
The stock symbol for Blau Farmaceutica is "BLAU3."
Does Blau Farmaceutica Pay Dividends? What’s The Current Dividend Yield?
The Blau Farmaceutica dividend yield is 5.99%.
What Is the Blau Farmaceutica Market Cap?
As of today, Blau Farmaceutica market cap is 2.58B BRL.
What Is Blau Farmaceutica's Earnings Per Share (TTM)?
The Blau Farmaceutica EPS (TTM) is 1.28.
When Is the Next Blau Farmaceutica Earnings Date?
Blau Farmaceutica will release its next earnings report on May 12, 2026.
From a Technical Analysis Perspective, Is BLAU3 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Blau Farmaceutica Stock Split?
Blau Farmaceutica has split 1 times.
How Many Employees Does Blau Farmaceutica Have?
Blau Farmaceutica has 1900 employees.
What is the current trading status of Blau Farmaceutica (BLAU3)?
As of Apr 15, 2026, Blau Farmaceutica (BLAU3) is trading at a price of 11.52 BRL, with a previous close of 11.17 BRL. The stock has fluctuated within a day range of 11.16 BRL to 11.52 BRL, while its 52-week range spans from 8.57 BRL to 11.58 BRL.
What Is Blau Farmaceutica (BLAU3) Price Target According to Analysts?
The average 12-month price target for Blau Farmaceutica is 12.85 BRL, with a high estimate of 18 BRL and a low estimate of 11 BRL. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +11.58% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.